Table 5 Contrasts arm by arm for each time point of follow-up

From: Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

 

LEV-3 vs PLA

LEV-5 vs PLA

LEV-5 vs LEV-3

Time

Contrasts and 95% CI

P-values

Contrasts and 95% CI

P-values

Contrasts and 95% CI

P-values

Day 1

0,50 [−13.6; 14.6]

0.945

−0.4 [14.3; −15.1]

0.956

−0.9 [13.4; −15.2]

0.900

Day 3

−30.7 [−16.1; −45.4]

<0.001

−31.9 [−16.7; −47.0]

<0.001

−1.1 [13.6; −15.8]

0.880

Day 5

−26.9 [−11.9; −41.9]

<0.001

−41.8 [−26.2; −57.4]

<0.001

−14.9 [0.2; −30.1]

0.053

Day 7

−16.9 [−0.5; −33.2]

0.043

−40.7 [−23.2; −58.2]

<0.001

−23.8 [−6.8; −40.9]

0.006

Day 15

−12.9 [4.7; −30.5]

0.152

−23.3 [−4.9; −41.7]

0.013

−10.5 [7.3; −28.3]

0.248

Day 30

−7.1 [15.4; −29.6]

0.535

−23.0 [0.4; −46.5]

0.054

−15.9 [6.9; −38.7]

0.172

  1. Pairwise comparisons using two-sided Wald tests. Exact p-values are reported. No correction for multiple testing was applied. 95% CI: 95% confidence interval.
Back to article page